We are grateful to our funders
Duchenne Research Fund.
The Human Frontier Science Program (HFSP) aims to stop Duchenne muscular dystrophy being a death sentence for hundreds of thousands of boys worldwide. We are helping turn the hope of treatments into reality. Critical supportive drugs are in clinical trial thanks to our funds. News item on how we support an AI approach to help accelerate future treatments for Duchenne muscular dystrophy.
Human Frontier Science Program.
The Human Frontier Science Program (HFSP) is an international program of research support, funding frontier research on the complex mechanisms of living organisms. Research is funded at all levels of biological complexity from biomolecules to the interactions between organisms.
Horizon 2020 is the biggest EU Research and Innovation programme ever with nearly €80 billion of funding available over 7 years (2014 to 2020) – in addition to the private investment that this money will attract. It promises more breakthroughs, discoveries and world-firsts by taking great ideas from the lab to the market.
National Institute for Health Research
The National Institute for Health Research (NIHR) is the largest national clinical research funder in Europe with a budget of over £1 billion (approximately USD 1.3 billion) in 2015-16. National Institute for Health Research funds health and care research and translates discoveries into practical products, treatments, devices and procedures, involving patients and the public in all our work. We ensure the NHS is able to support the research of other funders to encourage broader investment in, and economic growth from, health research. We work with charities and the life sciences industry to help patients gain earlier access to breakthrough treatments and we train and develop researchers to keep the nation at the forefront of international research.
Biotechnology and Biological Sciences Research Council
Biotechnology and Biological Sciences Research Council (BBSRC) is a UK Research Council and NDPB and is the largest UK public funder of non-medical bioscience. It predominantly funds scientific research institutes and university research departments in the UK. Our vision is to lead world-class 21st century bioscience, promoting innovation in the bioeconomy and realising benefits for society within and beyond the UK. We invested £469 million in world-class bioscience in 2016-17.
The Medical Research Council (MRC)
The Medical Research Council (MRC) is a publicly funded government agency responsible for co-ordinating and funding medical research in the United Kingdom. It is one of seven Research Councils in the UK and is answerable to, although politically independent from, the Department for Business, Innovation and Skills.
The MRC focuses on high-impact research and has provided the financial support and scientific expertise behind a number of medical breakthroughs, including the development of penicillin and the discovery of the structure of DNA. Research funded by the MRC has produced 30 Nobel Prize winners to date.
The Engineering and Physical Sciences Research Council (EPSRC)
EPSRC is the main UK government agency for funding research and training in engineering and the physical sciences, investing more than £800 million a year in a broad range of subjects – from mathematics to materials science, and from information technology to structural engineering.
Duchenne Research Fund
We aim to stop Duchenne muscular dystrophy being a death sentence for hundreds of thousands of boys worldwide. We are helping turn the hope of treatments into reality. Critical supportive drugs are in clinical trial thanks to our funds. In the last 3 years we have given more than £1.5m to ground-breaking research projects. And there is still work to do.
The Royal Society
The Royal Society is a Fellowship of many of the world’s most eminent scientists and is the oldest scientific academy in continuous existence. The Society’s fundamental purpose, reflected in its founding Charters of the 1660s, is to recognise, promote, and support excellence in science and to encourage the development and use of science for the benefit of humanity.
The Society has played a part in some of the most fundamental, significant, and life-changing discoveries in scientific history and Royal Society scientists continue to make outstanding contributions to science in many research areas.
The Boehringer Ingelheim Fonds
The Boehringer Ingelheim Fonds (BIF) is a public foundation – an independent, non-profit organization for the exclusive and direct promotion of basic research in biomedicine. We support up-and-coming junior scientists whose research projects experimentally elucidate the basic phenomena of human life, and organize two International Titisee Conferences per year. We are convinced that great scientific ideas and developments need a stimulating context, freedom and a sound financial fundament. At BIF, we do our best to provide all these for our fellows in our programmes.
The Studienstiftung des deutschen Volkes
Largest and oldest German sponsorship organisation for the academically gifted, promoting future excellence, funding, foundation, scholars. The Studienstiftung des deutschen Volkes – German Academic Scholarship Foundation – awards scholarships to outstanding students, irrespective of their political, ideological or religious convictions and affiliations. In line with its statutes, it supports “the university education of young people who, on account of their exceptional academic or artistic talents and their personalities, can be expected to make an outstanding contribution to society as a whole”.
The Luxembourg National Research Fund
The Luxembourg National Research Fund (FNR) is the main funder of research activities in Luxembourg. We invest public funds and private donations into research projects in various branches of science and the humanities, with an emphasis on selected core strategic areas. Furthermore, we support and coordinate activities to strengthen the link between science and society and to raise awareness for research. We also advise the Luxembourg government on research policy and strategy.
The Ministry of Education of the Republic of China
The Ministry of Education of the Republic of China is the ministry responsible for incorporating educational policies and managing public schools in the Republic of China (Taiwan).
The ideal of all education workers is for our children to enjoy going to school and to enjoy learning, and so the Ministry of Education is steadfastly committed to “replacing the right to a basic education with the right to learn, for all citizens, and providing education that is genuinely learner-centered”. This is our policy focus. The students are what education is all about and their development is at its core. We are building a diversified education system, and planning education measures for adaptive learning, to nurture students and equip them with six core competencies: namely problem solving, life aesthetics, digital interdisciplinary integration, independent reasoning, teamwork spirit, and multi-faceted creativity, and encourage their multi-faceted adaptive development.
Fresenius Kabi is a global health care company that specialises in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients.
With our corporate philosophy of “caring for life”, we are committed to putting essential medicines and technologies in the hands of people who help patients and finding the best answers to the challenges they face.
A global technology leader at the heart of our connected world.
Powered by the research and innovation of Nokia Bell Labs, we serve communications service providers, governments, large enterprises and consumers, with the industry’s most complete, end-to-end portfolio of products, services and licensing. From the enabling infrastructure for 5G and the Internet of Things, to emerging applications in virtual reality and digital health, we are shaping the future of technology to transform the human experience. A truly global company, we are 160 nationalities working in more than 100 countries.